DMAC vs FOX · $157.4M cap vs P/E 13, rev $16.30B
DiaMedica Therapeutics Inc (DMAC) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Fox Corp Class B (FOX) is a entertainment company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
DMAC currently screens at market cap $157.4M. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the DMAC and FOX stock pages for the full models.
Not investment advice.